Cargando…
Isoliquiritigenin decreases the incidence of colitis-associated colorectal cancer by modulating the intestinal microbiota
Imbalances in intestinal bacteria correlate with colitis-associated colorectal cancer (CAC). Traditional Chinese medicines have been used to adjust the gut microbiota, and isoliquiritigenin (ISL), a flavonoid extracted from licorice, has shown antitumor efficacy. In this study, the effects of ISL on...
Autores principales: | Wu, Minna, Wu, Yaqi, Deng, Baoguo, Li, Jinsong, Cao, Haiying, Qu, Yan, Qian, Xinlai, Zhong, Genshen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356739/ https://www.ncbi.nlm.nih.gov/pubmed/27863401 http://dx.doi.org/10.18632/oncotarget.13347 |
Ejemplares similares
-
Chitooligosaccharides Prevents the Development of Colitis-Associated Colorectal Cancer by Modulating the Intestinal Microbiota and Mycobiota
por: Wu, Minna, et al.
Publicado: (2019) -
Interplay between the Gut Microbiome and Metabolism in Ulcerative Colitis Mice Treated with the Dietary Ingredient Phloretin
por: Ren, Jie, et al.
Publicado: (2021) -
The Differences between Luminal Microbiota and Mucosal Microbiota in Mice
por: Wu, Minna, et al.
Publicado: (2020) -
The inhibitory effect of isoliquiritigenin on human platelets in vitro
por: Wu, Yingying, et al.
Publicado: (2023) -
Colon-specific delivery of isoliquiritigenin by oral edible zein/caseate nanocomplex for ulcerative colitis treatment
por: Xiao, Meng, et al.
Publicado: (2022)